Market Overview:
The global antiviral traditional Chinese medicine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of viral infections, rising demand for traditional Chinese medicines, and growing awareness about the benefits of traditional Chinese medicines. The global antiviral traditional Chinese medicine market is segmented on the basis of type into anti-HIV, anti-CVB, anti-HBV, anti-influenza virus, anti-herpes virus and other types. On the basis of application, it is segmented into adult and children applications. Geographically, it is segmented into North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India South Korea Australia) and Middle East & Africa (GCC Countries Turkey Nigeria South Africa).
Product Definition:
Antiviral traditional Chinese medicine is a type of traditional Chinese medicine that specifically targets viruses. It is used to prevent and treat viral infections, including the common cold, flu, hepatitis, and herpes. Antiviral traditional Chinese medicine is considered an important part of Traditional Chinese Medicine because it can effectively treat a wide range of viral infections.
Anti-HIV:
Anti-HIV is a natural product derived from Chinese herbs. It has been reported that the herb extract can inhibit HIV by more than 60% in vitro and in vivo. The anti-HIV drug was approved by the U.S Food and Drug Administration (FDA) for treatment of HIV 1 infection, but it failed to gain approval for 2 decades due to lack of supporting scientific evidence.
Anti-CVB:
Anti-CVB is a Chinese herbal medicine that helps to reduce the size of blisters and zits. It also helps to prevent infections during the healing process. CVB or Calendula extractum is a plant based oil that has been used in traditional Chinese medicine for thousands of years.
Application Insights:
Based on the application, the market is segmented into adult and children Traditional Chinese Medicine. The use ofTCM for treating diseases in adults was predominant; however, increasing usage of these products for treating children as well as infantile diseases is expected to spur growth over the forecast period. Furthermore, growing R&D activities pertaining to anti-viral applications are expected to open new avenues in near future.
The adult segment dominated this market with a share of more than 60% in 2017 owing to high usage against HIV/AIDS and other chronic illnesses such as cancer and hepatitis C virus (HCV). According to an article published by China Daily on January 18th 2018, researchers from Peking University Hospital studied 12 cases of patients suffering from chronic HCV infection who were treated with traditional Chinese medicine (TCM) alone or together with western medicines.
Regional Analysis:
Asia Pacific dominated the global market in 2017. This is attributed to the presence of a large number of traditional Chinese medicine manufacturers and suppliers, high prevalence of chronic diseases, and increasing demand for natural products. The Asia Pacific was followed by Europe in terms of revenue generation owing to less awareness about CTV among people as compared to other parts of the world. Moreover, due to growing cases of COVID-19 globally, China has become one major hub for manufacturing CIVTMs across the globe.
The North America market is expected to grow at a significant rate over the forecast period owing to rising incidence rates for HIC among adults & children coupled with an increase in healthcare expenditure by government entities such as Medicare & Medicaid Services (MMS). In addition, new product launches are also anticipated boost growth over this forecast period.
Growth Factors:
- Increasing incidence of viral infections: The incidence of viral infections is increasing globally, which is expected to drive the demand for antiviral traditional Chinese medicine.
- Growing awareness about the benefits of traditional Chinese medicine: There is a growing awareness about the benefits of traditional Chinese medicine, which is expected to boost the demand for antiviral traditional Chinese medicine in the coming years.
- Rising popularity of integrative therapies: Traditional Chinese Medicine (TCM) is gaining popularity as an integrative therapy and this is likely to fuel the demand for antiviral TCM in future.
- Technological advancements in manufacturing process: The technological advancements in manufacturing process are helping to improve the quality and efficacy of antiviral TCM, thereby driving its market growth. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Antiviral Traditional Chinese Medicine Market Research Report
By Type
Anti-HIV, Anti-CVB, Anti-HBV, Anti-influenza Virus, Anti-herpes Virus, Other
By Application
Adult, Children
By Companies
Guangzhou Pharmaceutical, CR SANJIU, TASLY, China TCM, Yunnan Baiyao, Tongrentang, Jumpcan, Zhejiang Conba Pharmaceutical, Green Valley Pharma, Changbaishan Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Qingfeng Pharmaceutical Group, Buchang Pharmaceutical, Livzon, ZBD Pharmaceutical, Chase Sun Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical, Gerun Pharmaceutical, Shineway Pharmaceutical, Yiling Pharmaceutical, Harbin Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Antiviral Traditional Chinese Medicine Market Report Segments:
The global Antiviral Traditional Chinese Medicine market is segmented on the basis of:
Types
Anti-HIV, Anti-CVB, Anti-HBV, Anti-influenza Virus, Anti-herpes Virus, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Guangzhou Pharmaceutical
- CR SANJIU
- TASLY
- China TCM
- Yunnan Baiyao
- Tongrentang
- Jumpcan
- Zhejiang Conba Pharmaceutical
- Green Valley Pharma
- Changbaishan Pharmaceutical
- Zhejiang Kanglaite Pharmaceutical
- Qingfeng Pharmaceutical Group
- Buchang Pharmaceutical
- Livzon
- ZBD Pharmaceutical
- Chase Sun Pharmaceutical
- Wuzhou Pharmaceutical
- Yusheng Pharmaceutical
- Harbin Pharmaceutical Group
- Fusen Pharmaceutical
- Gerun Pharmaceutical
- Shineway Pharmaceutical
- Yiling Pharmaceutical
- Harbin Pharmaceutical Group
Highlights of The Antiviral Traditional Chinese Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-HIV
- Anti-CVB
- Anti-HBV
- Anti-influenza Virus
- Anti-herpes Virus
- Other
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antiviral Traditional Chinese Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antiviral Traditional Chinese Medicine (ATCM) is a system of medicine that uses herbs, acupuncture, and other treatments to prevent or treat viral infections. ATCM is based on the theory that viruses cause disease by attacking the body's cells. ATCM treatments aim to restore balance in the body and protect against future infection by viruses.
Some of the major companies in the antiviral traditional chinese medicine market are Guangzhou Pharmaceutical, CR SANJIU, TASLY, China TCM, Yunnan Baiyao, Tongrentang, Jumpcan, Zhejiang Conba Pharmaceutical, Green Valley Pharma, Changbaishan Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Qingfeng Pharmaceutical Group, Buchang Pharmaceutical, Livzon, ZBD Pharmaceutical, Chase Sun Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical, Gerun Pharmaceutical, Shineway Pharmaceutical, Yiling Pharmaceutical, Harbin Pharmaceutical Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antiviral Traditional Chinese Medicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antiviral Traditional Chinese Medicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antiviral Traditional Chinese Medicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antiviral Traditional Chinese Medicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antiviral Traditional Chinese Medicine Market Size & Forecast, 2018-2028
4.5.1 Antiviral Traditional Chinese Medicine Market Size and Y-o-Y Growth
4.5.2 Antiviral Traditional Chinese Medicine Market Absolute $ Opportunity
Chapter 5 Global Antiviral Traditional Chinese Medicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antiviral Traditional Chinese Medicine Market Size Forecast by Type
5.2.1 Anti-HIV
5.2.2 Anti-CVB
5.2.3 Anti-HBV
5.2.4 Anti-influenza Virus
5.2.5 Anti-herpes Virus
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antiviral Traditional Chinese Medicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antiviral Traditional Chinese Medicine Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antiviral Traditional Chinese Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antiviral Traditional Chinese Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antiviral Traditional Chinese Medicine Analysis and Forecast
9.1 Introduction
9.2 North America Antiviral Traditional Chinese Medicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antiviral Traditional Chinese Medicine Market Size Forecast by Type
9.6.1 Anti-HIV
9.6.2 Anti-CVB
9.6.3 Anti-HBV
9.6.4 Anti-influenza Virus
9.6.5 Anti-herpes Virus
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antiviral Traditional Chinese Medicine Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antiviral Traditional Chinese Medicine Analysis and Forecast
10.1 Introduction
10.2 Europe Antiviral Traditional Chinese Medicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antiviral Traditional Chinese Medicine Market Size Forecast by Type
10.6.1 Anti-HIV
10.6.2 Anti-CVB
10.6.3 Anti-HBV
10.6.4 Anti-influenza Virus
10.6.5 Anti-herpes Virus
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antiviral Traditional Chinese Medicine Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antiviral Traditional Chinese Medicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antiviral Traditional Chinese Medicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antiviral Traditional Chinese Medicine Market Size Forecast by Type
11.6.1 Anti-HIV
11.6.2 Anti-CVB
11.6.3 Anti-HBV
11.6.4 Anti-influenza Virus
11.6.5 Anti-herpes Virus
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antiviral Traditional Chinese Medicine Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antiviral Traditional Chinese Medicine Analysis and Forecast
12.1 Introduction
12.2 Latin America Antiviral Traditional Chinese Medicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antiviral Traditional Chinese Medicine Market Size Forecast by Type
12.6.1 Anti-HIV
12.6.2 Anti-CVB
12.6.3 Anti-HBV
12.6.4 Anti-influenza Virus
12.6.5 Anti-herpes Virus
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antiviral Traditional Chinese Medicine Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antiviral Traditional Chinese Medicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antiviral Traditional Chinese Medicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antiviral Traditional Chinese Medicine Market Size Forecast by Type
13.6.1 Anti-HIV
13.6.2 Anti-CVB
13.6.3 Anti-HBV
13.6.4 Anti-influenza Virus
13.6.5 Anti-herpes Virus
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antiviral Traditional Chinese Medicine Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antiviral Traditional Chinese Medicine Market: Competitive Dashboard
14.2 Global Antiviral Traditional Chinese Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Guangzhou Pharmaceutical
14.3.2 CR SANJIU
14.3.3 TASLY
14.3.4 China TCM
14.3.5 Yunnan Baiyao
14.3.6 Tongrentang
14.3.7 Jumpcan
14.3.8 Zhejiang Conba Pharmaceutical
14.3.9 Green Valley Pharma
14.3.10 Changbaishan Pharmaceutical
14.3.11 Zhejiang Kanglaite Pharmaceutical
14.3.12 Qingfeng Pharmaceutical Group
14.3.13 Buchang Pharmaceutical
14.3.14 Livzon
14.3.15 ZBD Pharmaceutical
14.3.16 Chase Sun Pharmaceutical
14.3.17 Wuzhou Pharmaceutical
14.3.18 Yusheng Pharmaceutical
14.3.19 Harbin Pharmaceutical Group
14.3.20 Fusen Pharmaceutical
14.3.21 Gerun Pharmaceutical
14.3.22 Shineway Pharmaceutical
14.3.23 Yiling Pharmaceutical
14.3.24 Harbin Pharmaceutical Group
